Dolutegravir-based anti-retroviral therapy is effective and safe in HIV–infected paediatric patients

Dolutegravir-based anti-retroviral therapy is effective and safe in HIV–infected paediatric patients

Abstract Background Treatment of HIV infection in adolescents is challenging due to long duration of therapy and poor adherence. Recently, the integrase strand transfer inhibitor dolutegravir (DTG) has been approved for the use in adolescents with HIV, but evidence in clinical practice is very limit...

Full description

Bibliographic Details
Main Authors: Eugenia Bruzzese, Andrea Lo Vecchio, Andrea Smarrazzo, Orsola Tambaro, Giulia Palmiero, Giovanni Bonadies, Alfredo Guarino
Format: Article
Language:English
Published: BMC 2018-03-01
Series:Italian Journal of Pediatrics
Subjects:
HIV
Dolutegravir
Integrase strand transfer inhibitor
Adolescent
Children
Compliance
Online Access:http://link.springer.com/article/10.1186/s13052-018-0469-x

Internet

http://link.springer.com/article/10.1186/s13052-018-0469-x

Similar Items